As per the bulk deal data on the NSE, BNP Paribas Arbitrage sold 5,14,463 equity shares or 1.43% stake of Solara Active Pharma Science at Rs 1,463 per share on Monday, 19 April 2021.
On the same day, the Scottish Oriental Smaller Companies Trust Plc bought 1,99,259 equity shares or 0.55% stake of Solara Active Pharma Science at Rs 1,462.25 per share via bulk deal on NSE.
As of 31 March 2021, BNP Paribas Arbitrage held 3.50% stake in Solara Active Pharma Science.
Shares of Solara Active Pharma fell 0.03% to Rs 1,461.30 on BSE. The scrip hit a high of Rs 1,520 and a low of Rs 1,455 so far.
On a consolidated basis, the company posted a 59.2% jump in net profit to Rs 65.78 crore on a 24.2% rise in net sales to Rs 426.69 crore in Q3 FY21 over Q3 FY20.
Bank of Baroda allots 55 crore shares worth ₹4,500 crore to QIBs
×
BNP Paribas Arbitrage, SBI Life, LIC, Nippon India Large Cap Fund, ICICI Prudential Business Cycle Fund each allotted more than 5% equity
Eligible qualified institutional buyers (QIBs), including BNP Paribas Arbitrage, SBI Life Insurance Company and Life Insurance Corporation of India, have been collectively allotted about 55 crore equity shares aggregating about ₹4,500 crore by the Capital Raising Committee of the Board of Directors of Bank of Baroda (BoB).
BoB’s qualified institutional placement (QIP) issue opened for subscription on February 25, 2021 and closed on March 2.
According to the bank’s regulatory filing, the issue price of ₹81.70 per equity share (including a premium of ₹79.70 per equity share) was at a discount of 5 per cent to the floor price of ₹85.98 per equity share determined as per SEBI Regulations for equity shares to be allotted to eligible QIBs in the issue.
Read more about Happiest Mind rises after BNP Paribas buys stake on Business Standard. Happiest Mind Technologies gained 1.82% to Rs 384 after BNP Paribas Arbitrage purchased 0.63% stake in the firm via bulk deal on Friday, 15 January 2021.